Bowei Li

786 total citations
25 papers, 582 citations indexed

About

Bowei Li is a scholar working on Surgery, Molecular Biology and Immunology. According to data from OpenAlex, Bowei Li has authored 25 papers receiving a total of 582 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Surgery, 6 papers in Molecular Biology and 6 papers in Immunology. Recurrent topics in Bowei Li's work include Peptidase Inhibition and Analysis (3 papers), Diabetes Treatment and Management (3 papers) and Parkinson's Disease Mechanisms and Treatments (2 papers). Bowei Li is often cited by papers focused on Peptidase Inhibition and Analysis (3 papers), Diabetes Treatment and Management (3 papers) and Parkinson's Disease Mechanisms and Treatments (2 papers). Bowei Li collaborates with scholars based in China, Macao and Tunisia. Bowei Li's co-authors include Yuanpeng Xia, Bo Hu, Ling Mao, Xueying Luo, Shengcai Chen, Yanan Li, Huijuan Jin, Zi‐Ming Ye, Ruiting Hu and Chao Qin and has published in prestigious journals such as Journal of Clinical Investigation, The FASEB Journal and Cellular and Molecular Life Sciences.

In The Last Decade

Bowei Li

22 papers receiving 578 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Bowei Li China 11 277 202 167 111 79 25 582
Song Ren Canada 18 186 0.7× 133 0.7× 100 0.6× 137 1.2× 163 2.1× 35 753
Sara McCurdy United States 11 201 0.7× 167 0.8× 78 0.5× 67 0.6× 59 0.7× 23 435
Rihao Qu United States 11 351 1.3× 199 1.0× 137 0.8× 42 0.4× 81 1.0× 23 661
Juan Vladimir de la Rosa Spain 11 251 0.9× 348 1.7× 77 0.5× 141 1.3× 87 1.1× 19 644
Charlotte Muret Switzerland 2 410 1.5× 532 2.6× 200 1.2× 52 0.5× 125 1.6× 4 886
Bin Lei China 16 472 1.7× 75 0.4× 204 1.2× 55 0.5× 54 0.7× 32 749
Tong Xu China 13 253 0.9× 146 0.7× 101 0.6× 57 0.5× 31 0.4× 25 543
Hann Low Australia 14 225 0.8× 125 0.6× 81 0.5× 181 1.6× 62 0.8× 19 569

Countries citing papers authored by Bowei Li

Since Specialization
Citations

This map shows the geographic impact of Bowei Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bowei Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bowei Li more than expected).

Fields of papers citing papers by Bowei Li

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bowei Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bowei Li. The network helps show where Bowei Li may publish in the future.

Co-authorship network of co-authors of Bowei Li

This figure shows the co-authorship network connecting the top 25 collaborators of Bowei Li. A scholar is included among the top collaborators of Bowei Li based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bowei Li. Bowei Li is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhang, Chaochao, et al.. (2025). Modulation of Stem Cell Survival and Engraftment: Implications for Stem Cell-Based Therapy. Theranostics. 15(17). 8840–8856.
2.
Li, Bowei, et al.. (2025). Global research landscape of robotic surgery in gynecologic oncology: a bibliometric analysis (2005–2025). Journal of Robotic Surgery. 19(1). 641–641.
3.
Li, Bowei, et al.. (2025). Trace metals induce microbial risk and antimicrobial resistance in biofilm in drinking water. npj Clean Water. 8(1). 4 indexed citations
4.
Wang, Mengmeng, Bowei Li, Shuke Nie, et al.. (2025). Asparagine endopeptidase cleaves apolipoprotein A1 and accelerates pathogenesis of atherosclerosis. Journal of Clinical Investigation. 135(10). 2 indexed citations
5.
Meng, Xin, et al.. (2025). Development of asparagine endopeptidase inhibitors for treating neurodegenerative diseases. Trends in Molecular Medicine. 31(4). 359–372. 3 indexed citations
6.
Qian, Zhengjiang, Zhi-Hao Wang, Bowei Li, et al.. (2024). Thy1-ApoE4/C/EBPβ double transgenic mice act as a sporadic model with Alzheimer’s disease. Molecular Psychiatry. 29(10). 3040–3055. 14 indexed citations
7.
Guo, Xiaoqing, Bowei Li, Feng Zhang, et al.. (2023). TREM2 promotes cholesterol uptake and foam cell formation in atherosclerosis. Cellular and Molecular Life Sciences. 80(5). 137–137. 45 indexed citations
8.
Qian, Zhengjiang, Bowei Li, Xin Meng, et al.. (2023). Inhibition of asparagine endopeptidase (AEP) effectively treats sporadic Alzheimer’s disease in mice. Neuropsychopharmacology. 49(3). 620–630. 11 indexed citations
9.
Li, Bowei, et al.. (2022). Evaluation of atrial anatomical remodeling in atrial fibrillation with machine-learned morphological features. International Journal of Computer Assisted Radiology and Surgery. 18(4). 603–610. 2 indexed citations
10.
Li, Bowei, et al.. (2022). Emerging Roles of Extracellular Vesicle-Delivered Circular RNAs in Atherosclerosis. Frontiers in Cell and Developmental Biology. 10. 804247–804247. 8 indexed citations
11.
Li, Bowei, et al.. (2022). Injection of Matrix Metalloproteinase-9 Leads to Ventricular Remodeling. Disease Markers. 2022. 1–12. 4 indexed citations
12.
Ding, Na, et al.. (2020). The plasma level of mCRP is linked to cardiovascular disease in antineutrophil cytoplasmic antibody-associated vasculitis. Arthritis Research & Therapy. 22(1). 9 indexed citations
13.
Yang, Hang, Yan Luo, Xueying Luo, et al.. (2020). The predictive accuracy of satellite sign for hematoma expansion in intracerebral hemorrhage: A meta-analysis. Clinical Neurology and Neurosurgery. 197. 106139–106139. 8 indexed citations
14.
Li, Bowei, Yuanpeng Xia, & Bo Hu. (2020). Infection and atherosclerosis: TLR-dependent pathways. Cellular and Molecular Life Sciences. 77(14). 2751–2769. 106 indexed citations
15.
Yang, Shuai, Yuanpeng Xia, Xueying Luo, et al.. (2019). Exosomal CagA derived from Helicobacter pylori-infected gastric epithelial cells induces macrophage foam cell formation and promotes atherosclerosis. Journal of Molecular and Cellular Cardiology. 135. 40–51. 67 indexed citations
16.
Ye, Zi‐Ming, Shuai Yang, Yuanpeng Xia, et al.. (2019). LncRNA MIAT sponges miR-149-5p to inhibit efferocytosis in advanced atherosclerosis through CD47 upregulation. Cell Death and Disease. 10(2). 138–138. 162 indexed citations
17.
Zhuo, Yangjia, Yu Zheng, Rujun Mo, et al.. (2017). High expression of ASPM correlates with tumor progression and predicts poor outcome in patients with prostate cancer. International Urology and Nephrology. 49(5). 817–823. 41 indexed citations
18.
He, Jingliang, Bowei Li, Wenjie Zhou, et al.. (2017). Chaetocin induces cell cycle arrest and apoptosis by regulating the ROS-mediated ASK-1/JNK signaling pathways. Oncology Reports. 38(4). 2489–2497. 18 indexed citations
20.
Zhou, Li, et al.. (2016). Identification of the Sites of 4-Hydroxy-2-Nonenal and Neprilysin Adduction Using a Linear Trap Quadrapole Velos Pro-Orbitrap Elite Mass Spectrometer. European Journal of Mass Spectrometry. 22(3). 133–139. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026